Spearheading the development of a novel PNP inhibitor poised to revolutionize treatment for leukaemia patients facing relapse post-stem cell transplantation.
| Website | http://www.laevoroc.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Leukemia Treatment, Stem Cell Transplantation, Cancer Treatment, Oncology, Hematology, Drug Development, Pharmaceutical Research, Clinical Trials, Biotechnology, Novel Therapeutics, Cancer Research, Pharmaceutical, Medicine, Healthcare, Biopharma, Immunotherapy, Targeted Therapy, Precision Medicine |
Looking for a particular Laevoroc employee's phone or email?
Jessica Kourniaktis is the COO of Laevoroc.
1 people are employed at Laevoroc.